2025-10-09 - Analysis Report
Okay, here's a comprehensive analysis of Procter & Gamble (PG), incorporating all the data you've provided.

## Procter & Gamble (PG) Stock Analysis

**Ticker:** PG
**Company:** Procter & Gamble Co.
**Description:** Procter & Gamble is a multinational consumer goods corporation that manufactures and markets a wide range of branded products.

### 1. Performance vs. S&P 500 (VOO)

*   **PG Cumulative Return:** 31.13%
*   **VOO Cumulative Return:** 99.62%
*   **Absolute Divergence (PG - VOO):** -66.0%
*   **Divergence Range (Max: 24.9, Min: -66.2):**
    *   **Relative Divergence:** Approximately 0.2 (This indicates PG's performance is near the lower end of its historical divergence range compared to VOO.)

**Analysis:** PG has significantly underperformed the S&P 500 over the observed period. The relative divergence suggests this underperformance is near the worst it has been historically.

**Alpha and Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
| :----------- | :------ | :------ | :------ | :----- | :------ |
| 2015-2017  | 21.0%   | 7.9%    | -8.0%   | 0.0    | 215.0   |
| 2016-2018  | 9.0%    | 67.3%   | -6.0%   | 0.1    | 215.1   |
| 2017-2019  | 24.0%   | 70.4%   | 2.0%    | 0.3    | 292.3   |
| 2018-2020  | 27.0%   | 78.8%   | 4.0%    | 0.4    | 325.7   |
| 2019-2021  | 41.0%   | 78.8%   | -5.0%   | 0.5    | 382.9   |
| 2020-2022  | 13.0%   | 79.4%   | 13.0%   | 0.6    | 354.7   |
| 2021-2023  | 26.0%   | 79.4%   | 24.0%   | 0.4    | 343.0   |
| 2022-2024  | 9.0%    | 79.4%   | -12.0%  | 0.4    | 392.4   |
| 2023-2025  | -13.0%  | 80.1%   | -77.0%  | 0.2    | 352.7   |

**Analysis:**

*   **CAGR:** Fluctuates significantly, with a recent downturn in 2023-2025.
*   **MDD:** High maximum drawdown values indicate periods of substantial losses.
*   **Alpha:**  Inconsistent alpha suggests that PG's excess return compared to its benchmark varies. The recent negative alpha indicates underperformance.
*   **Beta:** The beta values are generally low, suggesting PG is less volatile than the overall market.
*   **Cap:**  Market capitalization remains substantial, indicating a large, established company.

### 2. Recent Stock Price Movements

*   **Current Price:** 150.69
*   **Previous Close:** 152.54
*   **Change:** -1.21
*   **5-Day Moving Average:** 151.59
*   **20-Day Moving Average:** 154.32
*   **60-Day Moving Average:** 155.42

**Analysis:**  The stock price is below all three moving averages (5-day, 20-day, and 60-day), indicating a short-term downward trend. The recent price decrease of -1.21, along with the price being below the moving averages, confirms a potential short-term bearish sentiment.

### 3. Market Risk Indicator & Other Indices

*   **MRI:** 0.9 (High Investment Recommended)
*   **RSI:** 27.71 (Oversold)
*   **PPO:** -0.20 (Bearish)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)
*   **Delta_Previous_Relative_Divergence (20-day):** -0.9 (Short-term decline)
*   **Expected Return:** 302.7% (Long-term, relative to S&P 500 if investing regularly)

**Analysis:**

*   **MRI:** Despite other indicators, the MRI suggests a high investment recommendation, possibly due to PG's established nature and long-term stability.
*   **RSI:**  The RSI indicates that the stock is currently oversold, which *could* signal a potential buying opportunity.
*   **PPO:** The negative PPO supports the short-term downward trend indicated by the moving averages.
*   **Delta_Previous_Relative_Divergence:** Reinforces the short-term negative momentum.
*   **Expected Return:** The significantly high expected return suggests a potentially lucrative long-term investment if PG's performance improves relative to the S&P 500.
*   **Price Change Reflection:** The recent price change of -1.21, while not drastic, confirms the negative trend seen in other indicators.

### 4. Recent News & Significant Events

*   **UBS Adjusts Price Target:** A slight reduction in price target from UBS ($180 to $176) while maintaining a "Buy" rating suggests continued confidence but with moderated expectations.
*   **Earnings Report Preview:** Upcoming earnings are being anticipated, which can create short-term volatility.
*   **Pakistan Operations Cut:** Restructuring and cutting operations in Pakistan indicates cost-cutting measures and potential challenges in specific markets.
*   **Annual Meeting Webcast:** The upcoming annual meeting is unlikely to have an immediate impact on stock price, but is relevant to governance.
*   **Stock Declines:** News highlighting recent stock declines reflects the negative sentiment seen in the price movement data.

### 4-2. Analyst Opinions

*   **Consensus:** "Buy" (Mean: 2.04)
*   **Target Price:** $169.64 (Average), $186.00 (High), $147.00 (Low)
*   **Recent Rating Changes:** No recent rating changes indicated.

**Analysis:**  Analysts generally have a positive outlook on PG, with a consensus "Buy" rating and an average target price significantly above the current price. However, the wide range of target prices indicates some uncertainty.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출        |
| :--------- | :--- | :---------- |
| 2025-04-24 | 1.58 | 19.78 B$    |
| 2025-01-22 | 1.94 | 21.88 B$    |
| 2024-10-18 | 1.65 | 21.74 B$    |
| 2024-04-19 | 1.56 | 20.20 B$    |
| 2025-04-24 | 1.56 | 20.20 B$    |

**Analysis:** The data shows fluctuating EPS and revenue figures over the recent quarters. This variability might contribute to investor uncertainty and the recent underperformance. It is importatnt to note that the last two entry dates are the same. It would be helpful to check the values again

### 6. Financial Information

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-06-30   | $20.89B   | 49.11%        |
| 2025-03-31   | $19.78B   | 50.98%        |
| 2024-12-31   | $21.88B   | 52.39%        |
| 2024-09-30   | $21.74B   | 52.06%        |
| 2024-06-30   | $20.53B   | 49.60%        |

**Analysis:** Revenue is relatively stable, but with slight fluctuations. Profit margins are high, indicating good operational efficiency, but there has been a slight decrease recently.

| Quarter      | Equity     | ROE     |
| :----------- | :--------- | :------ |
| 2025-06-30   | $52.01B   | 6.95%   |
| 2025-03-31   | $52.27B   | 7.21%   |
| 2024-12-31   | $51.17B   | 9.05%   |
| 2024-09-30   | $51.84B   | 7.64%   |
| 2024-06-30   | $50.29B   | 6.24%   |

**Analysis:** Equity is stable, and ROE (Return on Equity) is good, although there has been a recent decrease. This decrease could be contributing to the recent negative sentiment towards the stock.

### 7. Overall Summary and Investment Recommendation

**Summary:**

*   PG has significantly underperformed the S&P 500 recently.
*   Technical indicators suggest a short-term downward trend and oversold conditions.
*   Analyst consensus is positive ("Buy"), but target prices vary.
*   Financials show stable revenue and high profit margins, but recent declines in ROE could be a concern.
*   Recent news includes restructuring efforts and slightly lowered price targets.

**Investment Recommendation:**

The current situation is mixed. While the MRI suggests a high investment recommendation and the oversold RSI *could* signal a buying opportunity, the underperformance relative to the S&P 500, negative short-term trends, and recent restructuring efforts raise concerns.

**Recommendations:**

*   **Cautious Approach:** Given the conflicting signals, a cautious approach is warranted.
*   **Monitor Earnings:** Closely monitor upcoming earnings reports to gauge the company's performance and outlook.
*   **Long-Term Potential:** The high expected return suggests that PG *could* be a good long-term investment if it can improve its performance relative to the market.
*   **Consider Dollar-Cost Averaging:** If you believe in the long-term potential of PG, consider dollar-cost averaging to mitigate the risk of buying at a high price.

**Disclaimer:** This analysis is based on the provided data and should not be considered financial advice. Conduct thorough research and consult with a financial advisor before making any investment decisions.
